Quantbot Technologies’s BridgeBio Pharma BBIO Stock Holding History

Quantbot Technologies’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.1K	Buy	+162	New	+$11.3K	﹤0.01%	1821
2024 Q1	–	Sell	-1,410	Closed	-$56.9K	–	1559
2023 Q4	$56.9K	Buy	+1,410	New	+$42.3K	﹤0.01%	1312
2023 Q2	–	Sell	-2,800	Closed	-$46.4K	–	1576
2023 Q1	$46.4K	Buy	+2,800	New	+$32.6K	﹤0.01%	1262
2022 Q4	–	Sell	-32,995	Closed	-$327K	–	1677
2022 Q3	$327K	Buy	32,995 +31,028	+1,577%	+$322K	0.02%	723
2022 Q2	$17K	Sell	1,967 -2,233	-53%	-$18.7K	﹤0.01%	1462
2022 Q1	$42K	Buy	4,200 +3,500	+500%	+$35.9K	﹤0.01%	1234
2021 Q4	$11K	Sell	700 -10,858	-94%	-$459K	﹤0.01%	1302
2021 Q3	$541K	Buy	11,558 +9,258	+403%	+$496K	0.04%	575
2021 Q2	$140K	Buy	+2,300	New	+$131K	0.01%	837
2021 Q1	–	Sell	-1,100	Closed	-$78K	–	1412
2020 Q4	$78K	Buy	1,100 +700	+175%	+$33.8K	0.01%	790
2020 Q3	$15K	Buy	+400	New	+$12.6K	﹤0.01%	1045

Other funds holding BBIO

Jupiter Topco New York $245B AUM

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Quantbot Technologies's BBIO Position: Q2 2026 in Review

Quantbot Technologies opened a new position in BridgeBio Pharma (BBIO) in Q2 2026: 162 shares worth $12.1K. The stake represents ﹤0.01% of the portfolio and ranks #1821 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in BBIO as recently as Q4 2023.

Quantbot Technologies first reported a position in BBIO in Q3 2020 and has held it in 11 quarters since. The position peaked at $541K in Q3 2021. 475 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

Quantbot Technologies held 162 shares of BridgeBio Pharma worth $12.1K as of Q2 2026.
BridgeBio Pharma was a new Quantbot Technologies position in Q2 2026.
BridgeBio Pharma made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1821 holding.
Quantbot Technologies first reported a position in BridgeBio Pharma in Q3 2020 and has held it in 11 quarters since.
Quantbot Technologies's BridgeBio Pharma position peaked at $541K in Q3 2021.
475 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.